U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 761373
Company: SAMSUNG BIOEPIS CO LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
PYZCHIVA USTEKINUMAB-TTWE 45MG/0.5ML INJECTABLE;INJECTION Prescription None No No
PYZCHIVA USTEKINUMAB-TTWE 90MG/ML INJECTABLE;INJECTION Prescription None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/30/2025 ORIG-2 Approval N/A Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig2s000,761425Orig2s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761373Orig2s000; 761425Orig2s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761373Orig2s000,761425Orig2s000TOC.cfm
06/28/2024 ORIG-1 Approval N/A Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig1s001;761425Orig1s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761373Orig1s000;761425Orig1s000correctedltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761373Orig1s000,761425Orig1s000TOC.cfm
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/18/2025 SUPPL-6 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s006,761425s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761373Orig1s006;761425Orig1s005ltr.pdf
04/30/2025 SUPPL-4 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761373Orig1s004ltr.pdf
03/13/2025 SUPPL-3 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s003,761425s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761373Orig1s003, 761425Orig1s003ltr.pdf
12/20/2024 SUPPL-2 Supplement Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761373s002,761425s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761373Orig1s002,761425Orig1s002ltr.pdf
06/27/2025 SUPPL-1 Supplement Label (PDF)
Letter (PDF)
Summary Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig1s001;761425Orig1s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761373Orig1s001;761425Orig1s001ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2025/761373Orig1Orig2s001,761425Orig1Orig2s001CrossR.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/18/2025 SUPPL-6 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s006,761425s005lbl.pdf
11/18/2025 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s006,761425s005lbl.pdf
06/27/2025 SUPPL-1 Manufacturing (CMC)-Manufacturing Process Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig1s001;761425Orig1s001lbl.pdf
04/30/2025 SUPPL-4 Supplement Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s004lbl.pdf
04/30/2025 ORIG-2 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig2s000,761425Orig2s000lbl.pdf
03/13/2025 SUPPL-3 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s003,761425s003lbl.pdf
03/13/2025 SUPPL-3 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373s003,761425s003lbl.pdf
12/20/2024 SUPPL-2 Manufacturing (CMC)-Packaging Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761373s002,761425s002lbl.pdf
06/28/2024 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761373Orig1s001;761425Orig1s001lbl.pdf
Back to Top